Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (297)
ARTG (244)
Prescription medicine registration (23)

Date

2026 (2)
2025 (18)
2024 (49)
2023 (48)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (14)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Search

Sponsor content

564 result(s) found, displaying 31 to 40

PHARMACY CHOICE LEVONORGESTREL-1 levonorgestrel 1.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 March 2025

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PHARMACY HEALTH LEVONORGESTREL-1 levonorgestrel 1.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 March 2025

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
TERRYWHITE CHEMMART LEVONORGESTREL-1 levonorgestrel 1.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 March 2025

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PRICELINE PHARMACY LEVONORGESTREL-1 levonorgestrel 1.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 March 2025

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
VARENICLINE GH (Lupin Australia Pty Limited)

26 February 2025

Prescription medicine registration

Active ingredients: varenicline tartrate.
ARX-FENOFIBRATE fenofibrate 48 mg film-coated tablet blister pack (442670)

21 May 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ARX-FENOFIBRATE fenofibrate 48 mg film-coated tablet blister pack.
ARX-FENOFIBRATE fenofibrate 145 mg film-coated tablet blister pack (442671)

21 May 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ARX-FENOFIBRATE fenofibrate 145 mg film-coated tablet blister pack.
FENOFIBRATE-WGR fenofibrate 48 mg film-coated tablet blister pack (442650)

21 May 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FENOFIBRATE-WGR fenofibrate 48 mg film-coated tablet blister pack.
FENOFIBRATE-WGR fenofibrate 145 mg film-coated tablet blister pack (442651)

21 May 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FENOFIBRATE-WGR fenofibrate 145 mg film-coated tablet blister pack.
GANIRELIX GH (Lupin Australia Pty Limited)

4 December 2024

Prescription medicine registration

Active ingredients: ganirelix.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.